This content is in French.
Stem cell transplantation: ai to predict severe complications
18 février 2026
By Elodie Vaz | Published on February 18, 2026 | 3 min readEach year, thousands of patients undergo stem cell or bone marrow transplantation, often the only curative option for hematologic malignancies. While the acute phase of transplantation is now better controlled, late complications remain a major challenge. Among them, chronic graft-versus-host disease (cGVHD) remains one of the leading caus
Each year, thousands of patients undergo stem cell or bone marrow transplantation, often the only curative option for hematologic malignancies. While the acute phase of transplantation is now better controlled, late complications remain a major challenge. Among them, chronic graft-versus-host disease (cGVHD) remains one of the leading causes of morbidity and mortality after transplantation.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Paczesny S, et al. Predicting chronic graft-versus-host disease and transplant-related mortality using immune biomarkers and clinical data: development of the BIOPREVENT model. Journal of Clinical Investigation. 2026 Feb 16; 195228.
View the source
